Research progress of radionuclide labeled imaging agents targeting PD-1 and PD-L1 in the diagnosis of tumors.
- Published in:
- Japanese Journal of Nuclear Medicine / Kaku Igaku, 2019, v. 56, n. 1, p. 64
- By:
- Publication type:
- Article
Works by Sun, Yansha
Results: 10
1
2
The optimal time of starting adjuvant chemotherapy after curative surgery in patients with colorectal cancer.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10863-w
- By:
- Publication type:
- Article
3
Effect of immune checkpoint inhibitors in patients with gastric hepatoid adenocarcinoma: a case report and literature review.
- Published in:
- Journal of International Medical Research, 2022, v. 50, n. 4, p. 1, doi. 10.1177/03000605221091095
- By:
- Publication type:
- Article
4
Target-Dependent Expression of IL12 by synNotch Receptor-Engineered NK92 Cells Increases the Antitumor Activities of CAR-T Cells.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01448
- By:
- Publication type:
- Article
5
High expression of CXCL13 predicts a favorable response to immunotherapy by upregulating CXCR5+CD8+ T-cell infiltration in gastric cancer.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1551259
- By:
- Publication type:
- Article
6
Dual targeting chimeric antigen receptor cells enhance antitumour activity by overcoming T cell exhaustion in pancreatic cancer.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 22, p. 4628, doi. 10.1111/bph.16505
- By:
- Publication type:
- Article
7
Combinational zimberelimab plus lenvatinib and chemotherapy for alpha-fetoprotein elevated, advanced gastric cancer patients (AFPGC): a phase 1 dose-escalation study.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 8, p. 1, doi. 10.1007/s00262-024-03743-0
- By:
- Publication type:
- Article
8
An IL-4/21 Inverted Cytokine Receptor Improving CAR-T Cell Potency in Immunosuppressive Solid-Tumor Microenvironment.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01691
- By:
- Publication type:
- Article
9
Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12072-5
- By:
- Publication type:
- Article
10
Combined score based on plasma fibrinogen and platelet-lymphocyte ratio as a prognostic biomarker in esophageal squamous cell carcinoma.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-11968-6
- By:
- Publication type:
- Article